Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh
Given low prevalence and incidence of hyperkalemia and evident reduction in BP, our study suggests initiating FDC with telmisartan and amlodipine may be a practical and safe option for newly diagnosed hypertension, especially in resource-constrained settings where blood tests cannot be easily obtained.
Authors
- Mir Ishraquzzaman
- Fazila‐Tun‐Nesa Malik (ORCID: https://orcid.org/0000-0002-8424-439X)
- Sheikh Mohammad Mahbubus Sobhan
- Sohul Shuvo (ORCID: https://orcid.org/0000-0002-8510-6829)
- Junichi Ishigami (ORCID: https://orcid.org/0000-0002-6396-3723)
- Di Zhao (ORCID: https://orcid.org/0000-0002-9978-6773)
- Lawrence J. Appel (ORCID: https://orcid.org/0000-0002-0673-6823)
- Edgar R. Miller (ORCID: https://orcid.org/0000-0003-0157-6258)
- Sohel Reza Choudhury (ORCID: https://orcid.org/0000-0002-7498-4634)
- Md. Mahmudul Hasan (ORCID: https://orcid.org/0000-0003-3332-1823)
- Aruna Sarker
- Mohammad Abdullah Al Mamun (ORCID: https://orcid.org/0000-0002-3377-1122)
- Sharmin Nahar
- Kunihiro Matsushita
- Md Kalimuddin
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- National Heart Foundation Hospital & Research Institute (BD)
Publication Details
- Journal
- Global Heart
- Published
- 2025-03-19
- DOI
- https://doi.org/10.5334/gh.1415
- Citations
- 1
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.52